Anxiety Disorders

J. J. Benson-Martin, D. J. Stein, Eric Hollander

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This article briefly covers advances in the phenomenology, psychobiology, pharmacotherapy, and psychotherapy of the major anxiety disorders (generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, simple phobia, and social anxiety disorder). Reliable diagnosis of the different anxiety disorders is now possible, and a number of well-validated symptom severity measures are available for use in clinical and research assessments. Epidemiological and clinical surveys have demonstrated that the anxiety disorders are among the most prevalent, disabling, and costly of the psychiatric disorders. Advances in basic neuroscience and clinical research methods have contributed to understanding the neuroanatomy, neurochemistry, and neurogenetics of the anxiety disorders. Fortunately, a range of pharmacological agents and psychotherapeutic techniques have been shown to be effective and safe for the treatment of the anxiety disorders. More detailed understanding of the cognitive-affective neuroscience of the anxiety disorders may ultimately lead to future progress in treatment.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Neuroscience
PublisherElsevier Ltd
Pages493-497
Number of pages5
ISBN (Print)9780080450469
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Anxiety Disorders
Neurochemistry
Neuroanatomy
Panic Disorder
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorders
Neurosciences
Research
Psychotherapy
Psychiatry
Pharmacology
Drug Therapy
Therapeutics

Keywords

  • Anxiety disorders
  • Epidemiology
  • Neurochemistry
  • Neurocircuitry
  • Neurogenetics
  • Nosology
  • Pharmacotherapy
  • Psychotherapy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Benson-Martin, J. J., Stein, D. J., & Hollander, E. (2010). Anxiety Disorders. In Encyclopedia of Neuroscience (pp. 493-497). Elsevier Ltd. https://doi.org/10.1016/B978-008045046-9.00376-4

Anxiety Disorders. / Benson-Martin, J. J.; Stein, D. J.; Hollander, Eric.

Encyclopedia of Neuroscience. Elsevier Ltd, 2010. p. 493-497.

Research output: Chapter in Book/Report/Conference proceedingChapter

Benson-Martin, JJ, Stein, DJ & Hollander, E 2010, Anxiety Disorders. in Encyclopedia of Neuroscience. Elsevier Ltd, pp. 493-497. https://doi.org/10.1016/B978-008045046-9.00376-4
Benson-Martin JJ, Stein DJ, Hollander E. Anxiety Disorders. In Encyclopedia of Neuroscience. Elsevier Ltd. 2010. p. 493-497 https://doi.org/10.1016/B978-008045046-9.00376-4
Benson-Martin, J. J. ; Stein, D. J. ; Hollander, Eric. / Anxiety Disorders. Encyclopedia of Neuroscience. Elsevier Ltd, 2010. pp. 493-497
@inbook{0660c75676ed44188cba0de4c7ba318e,
title = "Anxiety Disorders",
abstract = "This article briefly covers advances in the phenomenology, psychobiology, pharmacotherapy, and psychotherapy of the major anxiety disorders (generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, simple phobia, and social anxiety disorder). Reliable diagnosis of the different anxiety disorders is now possible, and a number of well-validated symptom severity measures are available for use in clinical and research assessments. Epidemiological and clinical surveys have demonstrated that the anxiety disorders are among the most prevalent, disabling, and costly of the psychiatric disorders. Advances in basic neuroscience and clinical research methods have contributed to understanding the neuroanatomy, neurochemistry, and neurogenetics of the anxiety disorders. Fortunately, a range of pharmacological agents and psychotherapeutic techniques have been shown to be effective and safe for the treatment of the anxiety disorders. More detailed understanding of the cognitive-affective neuroscience of the anxiety disorders may ultimately lead to future progress in treatment.",
keywords = "Anxiety disorders, Epidemiology, Neurochemistry, Neurocircuitry, Neurogenetics, Nosology, Pharmacotherapy, Psychotherapy",
author = "Benson-Martin, {J. J.} and Stein, {D. J.} and Eric Hollander",
year = "2010",
doi = "10.1016/B978-008045046-9.00376-4",
language = "English (US)",
isbn = "9780080450469",
pages = "493--497",
booktitle = "Encyclopedia of Neuroscience",
publisher = "Elsevier Ltd",

}

TY - CHAP

T1 - Anxiety Disorders

AU - Benson-Martin, J. J.

AU - Stein, D. J.

AU - Hollander, Eric

PY - 2010

Y1 - 2010

N2 - This article briefly covers advances in the phenomenology, psychobiology, pharmacotherapy, and psychotherapy of the major anxiety disorders (generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, simple phobia, and social anxiety disorder). Reliable diagnosis of the different anxiety disorders is now possible, and a number of well-validated symptom severity measures are available for use in clinical and research assessments. Epidemiological and clinical surveys have demonstrated that the anxiety disorders are among the most prevalent, disabling, and costly of the psychiatric disorders. Advances in basic neuroscience and clinical research methods have contributed to understanding the neuroanatomy, neurochemistry, and neurogenetics of the anxiety disorders. Fortunately, a range of pharmacological agents and psychotherapeutic techniques have been shown to be effective and safe for the treatment of the anxiety disorders. More detailed understanding of the cognitive-affective neuroscience of the anxiety disorders may ultimately lead to future progress in treatment.

AB - This article briefly covers advances in the phenomenology, psychobiology, pharmacotherapy, and psychotherapy of the major anxiety disorders (generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, simple phobia, and social anxiety disorder). Reliable diagnosis of the different anxiety disorders is now possible, and a number of well-validated symptom severity measures are available for use in clinical and research assessments. Epidemiological and clinical surveys have demonstrated that the anxiety disorders are among the most prevalent, disabling, and costly of the psychiatric disorders. Advances in basic neuroscience and clinical research methods have contributed to understanding the neuroanatomy, neurochemistry, and neurogenetics of the anxiety disorders. Fortunately, a range of pharmacological agents and psychotherapeutic techniques have been shown to be effective and safe for the treatment of the anxiety disorders. More detailed understanding of the cognitive-affective neuroscience of the anxiety disorders may ultimately lead to future progress in treatment.

KW - Anxiety disorders

KW - Epidemiology

KW - Neurochemistry

KW - Neurocircuitry

KW - Neurogenetics

KW - Nosology

KW - Pharmacotherapy

KW - Psychotherapy

UR - http://www.scopus.com/inward/record.url?scp=84882839773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882839773&partnerID=8YFLogxK

U2 - 10.1016/B978-008045046-9.00376-4

DO - 10.1016/B978-008045046-9.00376-4

M3 - Chapter

AN - SCOPUS:84882839773

SN - 9780080450469

SP - 493

EP - 497

BT - Encyclopedia of Neuroscience

PB - Elsevier Ltd

ER -